🇺🇸 FDA
Pipeline program

PSMA-11 kit for Ga-68 labelling

2020/ABM/01/00074

Phase 3 small_molecule active

Quick answer

PSMA-11 kit for Ga-68 labelling for Intermediate and high-risk prostate cancer is a Phase 3 program (small_molecule) at Bial Portela & Companhia S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Bial Portela & Companhia S.A.
Indication
Intermediate and high-risk prostate cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials